Kyle Rose
Stock Analyst at Canaccord Genuity
(3.30)
# 855
Out of 4,810 analysts
122
Total ratings
49.49%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Kyle Rose
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNN Smith & Nephew | Maintains: Hold | $27 | $26.05 | +3.65% | 6 | Feb 26, 2025 | |
| PODD Insulet | Maintains: Buy | $304 → $324 | $255.47 | +26.83% | 16 | Feb 21, 2025 | |
| FNA Paragon 28 | Downgrades: Hold | n/a | $12.99 | - | 8 | Jan 29, 2025 | |
| SYK Stryker | Maintains: Buy | $420 → $435 | $353.42 | +23.08% | 20 | Jan 29, 2025 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $72.98 | -2.71% | 7 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $32.31 | +119.75% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $15.08 | +45.89% | 10 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.00 | +900.00% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $10.18 | +116.11% | 4 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $67.39 | +122.58% | 17 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $360 → $270 | $5.40 | +4,900.00% | 3 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $27 | $13.36 | +102.10% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.01 | +1,385.15% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $16.06 | -6.60% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $125 → $122 | $159.79 | -23.65% | 1 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $3 → $4 | $2.46 | +62.60% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $7.92 | - | 2 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $165 → $125 | $101.97 | +22.59% | 7 | Feb 8, 2022 |
Smith & Nephew
Feb 26, 2025
Maintains: Hold
Price Target: $27
Current: $26.05
Upside: +3.65%
Insulet
Feb 21, 2025
Maintains: Buy
Price Target: $304 → $324
Current: $255.47
Upside: +26.83%
Paragon 28
Jan 29, 2025
Downgrades: Hold
Price Target: n/a
Current: $12.99
Upside: -
Stryker
Jan 29, 2025
Maintains: Buy
Price Target: $420 → $435
Current: $353.42
Upside: +23.08%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $72.98
Upside: -2.71%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $32.31
Upside: +119.75%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $15.08
Upside: +45.89%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.00
Upside: +900.00%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $10.18
Upside: +116.11%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $67.39
Upside: +122.58%
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $5.40
Upside: +4,900.00%
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $13.36
Upside: +102.10%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $1.01
Upside: +1,385.15%
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $16.06
Upside: -6.60%
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $159.79
Upside: -23.65%
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $2.46
Upside: +62.60%
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $7.92
Upside: -
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $101.97
Upside: +22.59%